JP2008546810A5 - - Google Patents

Download PDF

Info

Publication number
JP2008546810A5
JP2008546810A5 JP2008518554A JP2008518554A JP2008546810A5 JP 2008546810 A5 JP2008546810 A5 JP 2008546810A5 JP 2008518554 A JP2008518554 A JP 2008518554A JP 2008518554 A JP2008518554 A JP 2008518554A JP 2008546810 A5 JP2008546810 A5 JP 2008546810A5
Authority
JP
Japan
Prior art keywords
mutilin
amino
cycloalkyl
acyloxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008518554A
Other languages
English (en)
Japanese (ja)
Other versions
JP5373393B2 (ja
JP2008546810A (ja
Filing date
Publication date
Priority claimed from GB0513060A external-priority patent/GB0513060D0/en
Priority claimed from GB0515997A external-priority patent/GB0515997D0/en
Application filed filed Critical
Priority claimed from PCT/AT2006/000260 external-priority patent/WO2007000004A1/en
Publication of JP2008546810A publication Critical patent/JP2008546810A/ja
Publication of JP2008546810A5 publication Critical patent/JP2008546810A5/ja
Application granted granted Critical
Publication of JP5373393B2 publication Critical patent/JP5373393B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008518554A 2005-06-27 2006-06-26 ヒドロキシアミノ基またはアシルオキシアミノシクロアルキル基を含むプレウロムチリン誘導体 Expired - Fee Related JP5373393B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0513060.4 2005-06-27
GB0513060A GB0513060D0 (en) 2005-06-27 2005-06-27 Organic compounds
GB0515997.5 2005-08-03
GB0515997A GB0515997D0 (en) 2005-08-03 2005-08-03 Organic compounds
PCT/AT2006/000260 WO2007000004A1 (en) 2005-06-27 2006-06-26 Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group

Publications (3)

Publication Number Publication Date
JP2008546810A JP2008546810A (ja) 2008-12-25
JP2008546810A5 true JP2008546810A5 (cg-RX-API-DMAC7.html) 2012-10-25
JP5373393B2 JP5373393B2 (ja) 2013-12-18

Family

ID=36764461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008518554A Expired - Fee Related JP5373393B2 (ja) 2005-06-27 2006-06-26 ヒドロキシアミノ基またはアシルオキシアミノシクロアルキル基を含むプレウロムチリン誘導体

Country Status (5)

Country Link
US (1) US7790767B2 (cg-RX-API-DMAC7.html)
EP (2) EP1896404B1 (cg-RX-API-DMAC7.html)
JP (1) JP5373393B2 (cg-RX-API-DMAC7.html)
TW (1) TW200730488A (cg-RX-API-DMAC7.html)
WO (1) WO2007000004A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1896404B1 (en) * 2005-06-27 2014-09-17 Nabriva Therapeutics AG Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
EP1808431A1 (en) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
EP1972618A1 (en) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
JP5322927B2 (ja) 2007-05-24 2013-10-23 杏林製薬株式会社 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2159220A1 (en) * 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organic compounds
AR090010A1 (es) 2011-04-15 2014-10-15 Bayer Cropscience Ag 5-(ciclohex-2-en-1-il)-penta-2,4-dienos y 5-(ciclohex-2-en-1-il)-pent-2-en-4-inos sustituidos como principios activos contra el estres abiotico de las plantas, usos y metodos de tratamiento
CN102229580B (zh) * 2011-05-12 2014-02-26 南通大学 新型截短侧耳素衍生物、其制备方法及其医药用途
BR112014000267A2 (pt) 2011-07-04 2016-09-20 Bayer Ip Gmbh utilização de isoquinolinonas, isoquinolinedionas, isoquinolinetrionas e dihidroisoquinolinonas substituídas ou, em cada caso, sais das mesmas como agentes ativos contra o stress abiótico em plantas
CN103204787B (zh) * 2012-01-17 2014-10-01 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
EP3096751B1 (en) * 2014-01-22 2021-01-06 Nabriva Therapeutics GmbH 12-epi-pleuromutilins
PT3310331T (pt) * 2015-06-17 2021-01-19 Nabriva Therapeutics GmbH Formulações farmacêuticas injetáveis de lefamulina
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
US20230174472A1 (en) * 2020-04-17 2023-06-08 Nabriva Therapeutics GmbH Therapeutic use of pleuromutilins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3054875B2 (ja) * 1995-02-13 2000-06-19 株式会社小松製作所 プラズマトーチ
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
CO5150194A1 (es) * 1999-01-27 2002-04-29 Abbott Lab Inhibidores hidroxamato inversos de las metalopreteinasas matriciales
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
WO2003040103A1 (en) * 2001-11-02 2003-05-15 Bristol-Myers Squibb Company β-SULFONE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
EP1896404B1 (en) * 2005-06-27 2014-09-17 Nabriva Therapeutics AG Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group

Similar Documents

Publication Publication Date Title
CN103492370B (zh) 取代的二氨基甲酰胺和二氨基甲腈嘧啶,其组合物,和用其治疗的方法
ES2655527T3 (es) Derivados novedosos de amino pirimidina
CA2574600A1 (en) Pyridine derivatives
JP2007508360A5 (cg-RX-API-DMAC7.html)
HRP20240157T1 (hr) Deuterirani derivati lanifibranora
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
NO20065613L (no) 3-karbamoyl-2-pyridonderivat.
ES2968840T3 (es) Compuestos de aminocarbonilcarbamato y su uso en el tratamiento de trastornos hipercinéticos tales como el TDAH
JP2007519721A5 (cg-RX-API-DMAC7.html)
JP2007533722A5 (cg-RX-API-DMAC7.html)
JP2006519852A5 (cg-RX-API-DMAC7.html)
ATE442349T1 (de) Diacylglycerol-acyltransferase-hemmer
RU2010107169A (ru) Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого
JP2009040767A5 (cg-RX-API-DMAC7.html)
JP2011529069A5 (cg-RX-API-DMAC7.html)
JP2004502755A5 (cg-RX-API-DMAC7.html)
AU2006325931A8 (en) Amine compound and use thereof for medical purposes
JP2010534246A5 (cg-RX-API-DMAC7.html)
JP2007501270A5 (cg-RX-API-DMAC7.html)
JP2010513489A5 (cg-RX-API-DMAC7.html)
CA3046196A1 (en) Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases
CN110612286A (zh) 氰基取代的稠合双环衍生物及其制备方法和用途
JP2008546679A5 (cg-RX-API-DMAC7.html)
EP4399208A1 (en) Irak inhibitor for treating cytokine release-related conditions associated with infection by a respiratory virus
JP2024517789A5 (cg-RX-API-DMAC7.html)